Notizia

Posted on


 

For Inflectra launch, Pfizer uses ‘hybrid model’ to home in on HCPs

US FDA approves Rubraca to treat advanced ovarian cancer

EMA approves MSD’s PD-1 therapy Keytruda to treat patients with NSCLC

Mylan launches authorized generic version of EpiPen

Source: Notizia

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s